ONCOSYNE AS
Signals
- Driftsunderskudd 2025 Siste driftsresultat er negativt (−3,1 mill kr).
ONCOSYNE AS is registered as a limited company in Oslo, Oslo with organisation number 926191942. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2020 and has 6 registered employees. Registered share capital is NOK 1.1m, divided into 1124801 shares. The company's stated purpose is: “Forskning og utviklingsarbeid innen medisinsk bioteknologi med det formål å tilby legemiddelscreening som en diagnostisk tjeneste. Legemiddelscreenen skal være et beslutningsverktøy for skånsom, presis og effektiv kreftbehandling.”. The most recent filed accounts, for the 2025 financial year, show NOK 4.2m in revenue and NOK −3.1m in operating profit.
Key figures · 2025
Financial health · 2025
Who owns ONCOSYNE AS?
ONCOSYNE AS has 13 registered shareholders:
- NORSKE OMVEIER AS 31.1%
- KAARSTAD SMIER AS 31.1%
- WIBO CONSULTING AS 8.8%
- DAEDALUS AS 6.3%
- STARTUPLAB FOUNDERS FUND IV AS 5.9%
- MILLIMEDIA AS 4.2%
- FORTRESS FUND 1 AS 3.4%
- FARVATN VENTURE AS 2.5%
- JO STRØMGREN 1.8%
- SVARTHØI HOLDING AS 1.8%
- JALCO CONSULTING AS 1.7%
- MIKKEL BOVIM BUGGE 0.9%
- LILLE PERSILLE FAMILIEBARNEHAGE AS 0.3%
Frequently asked questions about ONCOSYNE AS
Who owns ONCOSYNE AS?
NORSKE OMVEIER AS is the largest registered owner, with 31.1%.
What is the revenue of ONCOSYNE AS?
ONCOSYNE AS had revenue of NOK 4.2m in 2025.
Where is ONCOSYNE AS based?
ONCOSYNE AS has its business address in Oslo.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 02.09.2026.